0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
"Global OTC Drugs Market 2018-2024"
Published Date: April 2019
|
Report Code: INFO-Othe-325
Home | Market Reports |Business & Industrial |Pharmaceuticals & Biotech
Global OTC Drugs Market 2018 to 2024

"Global OTC Drugs Market 2018-2024"

Code: INFO-Othe-325
Report
April 2019
83 Pages
Infoholic Research
Region: North America, Europe, Asia Pacific, Global,
Description
Table of Content
Tables & Figures

Global Over the Counter Drugs Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018–2024
Overview: Over-the-counter medications, also known as non-prescription drugs, are the medicines that can be procured without a prescription from the doctor. When the directions on the label are followed, these drugs are harmless and effective. These drugs are principally used for the treatment of the health conditions that can be self-medicated.
OTC drugs are measured by government regulatory associations to be harmless for self-medication. According to Food and drug administration (FDA), there are more than 300,000 OTC drug product are marketed. Some of the common applications of OTC drugs are aches, pains, itches and others.
Merger and acquisition has always been a trend in the pharmaceutical industry. Recently in 2018 January, J&J, GlaxoSmithKline and Reckitt Benckiser are on race to buy Pfizer's $20 billion consumer. However, the final two competitors for the bid are GSK and Reckitt Benckiser. Other major trend in the market are product launch and approval, collaboration and business expansion. In July 2017, Glenmark gets MHRA approval for OTC sale of anti-malarial drug in Europe.
Market Analysis: The “Global Over the counter drugs” market is estimated to witness a CAGR of 6.1% during the forecast period 2017–2023. The over the counter drugs market is analyzed based on two segments –product types, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the global over the counter drugs market, followed by Europe, Asia Pacific, and Rest of the World.
Product Types Analysis: The OTC drugs demand for cold, cough and allergy will involve the classical seasonal drift, driving a stable progress during the forecast period. However, OTC drugs used for weight loss, smoking cessation and sleeping aid are on great demand in established regions. Many small manufacturers are establishing in these segment with their innovative products to have a strong foot hold. From the time of switching nicotine replacement therapies as OTC products, there was nearly 150% -200% increase in their procurement and usage in the initial year after the switch. Amplified access permitted many smokers to help quit smoking saving nearly $2 billion every year.
Key Players: Major players operating in the OTC market include Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson, and Sanofi, are the major players of the market. Teva Pharmaceutical Industries Ltd., Pfizer, Synergy Pharmaceuticals Inc, Innovus Pharmaceuticals, Procter & Gamble Company, Merck & Co, Takeda Pharmaceutical Co, Ltd, Boehringer Ingelheim GmbH and Sun Pharmaceutical Industries Ltd.
Competitive Analysis: Online sales of Over the counter drugs are transforming the market, intimidating major OTC drugs manufacturers and permitting small companies to obtain their share in the market. Aleve by Bayer is one of the best-selling drug in America with a revenue of $485 million in sales in 2016. But there was a drop-in sale by 10% in 2017. This was due to the availability of alternative drugs online from small manufacturers. This shows that the power is gradually shifting toward e-commerce, making it difficult for the major players.
Nevertheless, small companies are also facing patent litigation issues, making their entry more difficult into the market. For instance, Bayer AG filed a patent litigation against Perrigo Company plc’s Finacea Foam in the US district court in February 2018.
Benefits: The report provides complete details about the usage and adoption rate of over the counter drugs in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Table of Contents


1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Industry Trends 8
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 10
2.3 Research Methodology 11
2.4 Report Assumptions 11
3 Market Snapshot 12
3.1 Market Definition – Infoholic Research 13
3.2 Total Addressable Market (TAM) 13
3.3 Segmented Addressable Market (SAM) 13
3.3.1 Difference between OTCs and prescription (Rx) medicines 14
3.3.2 Trends of over the counter drug market 14
3.4 Related Addressable Markets (RAM) 15
3.4.1 Oncology (Cancer) Drugs 15
3.4.2 Active pharmaceutical ingredients (APIs) 16
3.4.3 Diabetes Drugs Market 16
4 Market Outlook 18
4.1 Regulatory Scenario 18
4.1.1 US: 18
4.1.2 Europe: 18
4.1.3 Japan: 18
4.1.4 Turkey 19
4.2 Market Segmentation 20
4.3 Porter 5(Five) Forces 21
4.4 PEST Analysis 22
5 Market Characteristics 23
5.1 Market Dynamics 23
5.1.1 Drivers 23
5.1.1.1 Conducive government legislation 23
5.1.1.2 Switching of Rx drugs to OTC drugs 24
5.1.1.3 Cost-effective OTC drugs 24
5.1.2 Opportunities 25
5.1.2.1 A growing pain category 25
5.1.2.2 An increase in self-care 25
5.1.3 Restraints 25
5.1.3.1 Incorrect self-diagnosis 25
5.1.3.2 Side Effects and Misuse of Over the Counter Drugs 25
5.1.4 DRO – Impact Analysis 26
5.1.5 Key Stakeholders 27
6 Product Types: Market Size and Analysis 29
6.1 Overview 29
6.1.1 Cold, Cough and Allergy 30
6.1.2 Analgesics 31
6.1.3 Dermatology OTC Drugs 32
6.1.4 Gastrointestinal OTC Drugs 33
6.1.5 Ophthalmic OTC drugs 34
6.1.6 Vitamins and Minerals Supplements 35
6.1.7 Others 36
7 Regions: Market Size and Analysis 38
7.1 Overview 38
7.2 North America 39
7.2.1 Overview 39
7.3 Europe 40
7.3.1 Overview 40
7.4 APAC 42
7.4.1 Overview 42
7.5 Rest of the World 43
7.5.1 Overview 43
8 Competitive Landscape 45
9 Vendor Profiles 50
9.1 Sanofi 50
9.1.1 Overview 50
9.1.2 Geographic Revenue 53
9.1.3 Business Focus 53
9.1.4 SWOT Analysis 54
9.1.5 Business Strategy 54
9.2 Bayer AG 55
9.2.1 Overview 55
9.2.2 Business Unit 57
9.2.3 Geographic Presence 58
9.2.4 Business Focus 58
9.2.5 SWOT Analysis 59
9.2.6 Business Strategy 59
9.3 Johnson & Johnson 59
9.3.1 Overview 59
9.3.2 Business Units 63
9.3.3 Geographic Revenue 64
9.3.4 Business Focus 65
9.3.5 SWOT Analysis 66
9.3.6 Business Strategies 66
9.4 GlaxoSmithKline plc 67
9.4.1 Overview 67
9.4.2 Geographic Presence 71
9.4.3 Business Focus 71
9.4.4 SWOT Analysis 72
9.4.5 Business Strategy 72
10 Companies to Watch For 73
10.1 Pfizer Inc., 73
10.1.1 Overview 73
10.1.2 Highlights 74
10.2 Synergy Pharmaceuticals Inc 74
10.2.1 Overview 74
10.2.2 Highlights 75
10.3 Innovus Pharmaceuticals 75
10.3.1 Overview 75
10.3.2 Highlights 75
10.4 Procter & Gamble Company 76
10.4.1 Overview 76
10.4.2 Highlights 76
10.5 Sun Pharmaceuticals. 77
10.5.1 Overview 77
10.5.2 Highlights 78
10.6 Merck & Co. 78
10.6.1 Overview 78
10.6.2 Highlights: 79
10.7 Takeda Pharmaceutical Co, Ltd 79
10.7.1 Overview 79
10.7.2 Highlights: 80
10.8 Boehringer Ingelheim GmbH 80
10.8.1 Overview 80
10.8.2 Highlights: 81
Annexure 82
Abbreviations 82


List of Tables

TABLE 1 OVER THE COUNTER DRUGS MARKET REVENUE BY PRODUCT TYPE SEGEMENTATION, 2017-2024 ($BILLION) 29
TABLE 2 OVER THE COUNTER DRUGS MARKET REVENUE BY REGIONS, 2017-2024 ($BILLION) 39
TABLE 3 OTHER PROMINENT VENDORS IN THE OVER THE COUNTER MARKET 46
TABLE 4 SANOFI: OFFERINGS 50
TABLE 5 SANOFI: RECENT DEVELOPMENTS 51
TABLE 6 BAYER AG: OFFERINGS 55
TABLE 7 BAYER AG: RECENT DEVELOPMENTS 55
TABLE 8 JOHNSON & JOHNSON: PRODUCT OFFERINGS 60
TABLE 9 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 61
TABLE 10 GLAXOSMITHKLINE PLC: OFFERINGS 67
TABLE 11 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 68
TABLE 12 PFIZER: OVERVIEW 73
TABLE 13 PFIZER: RECENT DEVELOPMENTS 73
TABLE 14 INNOVUS PHARMA: OVERVIEW 75
TABLE 15 PROCTER & GAMBLE COMPANY: OVERVIEW 76
TABLE 16 SUN PHARMACEUTICALS: OVERVIEW 77
TABLE 17 MERCK & CO: OVERVIEW 78
TABLE 18 MERCK & CO: RECENT DEVELOPMENTS 78
TABLE 19 TAKEDA PHARMACEUTICAL CO, LTD.: OVERVIEW 80
TABLE 20 BOEHRINGER INGELHEIM GMBH: OVERVIEW 80
TABLE 21 BOEHRINGER INGELHEIM GMBH: RECENT DEVELOPMENTS 81

List of Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL OVER THE COUNTER DRUGS MARKET 11
CHART 2 GLOBAL OVER THE COUNTER DRUGS MARKET REVENUE, 2017-2024 ($BILLION) 14
CHART 3 SEGMENTATION OF GLOBAL OVER THE COUNTER DRUGS MARKET 20
CHART 4 PORTER 5 FORCES OF OVER THE COUNTER DRUGS MARKET 21
CHART 5 PEST ANALYSIS OF OVER THE COUNTER DRUGS MARKET 22
CHART 6 MARKET DYNAMICS – DRO ANALYSIS 23
CHART 7 DRO – IMPACT ANALYSIS OF GLOBAL OVER THE COUNTER DRUGS MARKET 26
CHART 8 KEY STAKEHOLDERS 27
CHART 9 OVER THE COUNTER DRUGS MARKET BY PRODUCT TYPES SEGMENTATION, 2017 VS 2024 ($BILLION) 29
CHART 10 COLD COUGH AND ALLERGY OTC DRUGS MARKET BY PRODUCT TYPES SEGMENTATION, 2017-2024 ($BILLION) 31
CHART 11 ANELGESICS OTC DRUGS MARKET BY PRODUCT TYPES SEGMENTATION, 2017-2024 ($BILLION) 31
CHART 12 DERMATOLOGY OTC DRUGS MARKET BY PRODUCT TYPES SEGMENTATION, 2017-2024 ($BILLION) 33
CHART 13 GASTROINTESTINAL OTC DRUGS MARKET BY PRODUCT TYPES SEGMENTATION, 2016-2023 ($BILLION) 34
CHART 14 OPHTHALMIC OTC DRUGS MARKET BY PRODUCT TYPES SEGMENTATION, 2016-2023 ($BILLION) 35
CHART 15 VITAMINS AND MINERAL SUPPLEMENTS MARKET BY PRODUCT TYPES SEGMENTATION, 2016-2023 ($BILLION) 36
CHART 16 OTHER OTC DRUGS MARKET BY PRODUCT TYPES SEGMENTATION, 2016-2023 ($BILLION) 37
CHART 17 OVER THE COUNTER DRUGS MARKET BY REGIONAL SEGMENTATION, 2016 VS 2023 (%) 38
CHART 18 OVER THE COUNTER DRUGS MARKET REVENUE IN NORTH AMERICA, 2017-2024 ($BILLION) 40
CHART 19 OVER THE COUNTER DRUGS MARKET REVENUE IN THE EUROPE REGION, 2018–2024 ($BILLION) 41
CHART 20 OVER THE COUNTER DRUG MARKET REVENUE IN THE APAC REGION, 2017-2024 ($BILLION) 43
CHART 21 OVER THE COUNTER DRUGS MARKET REVENUE IN REST OF THE WORLD, 2017–2023 ($BILLION) 44
CHART 22 SANOFI SA: OVERVIEW SNAPSHOT 51
CHART 23 SANOFI SA: SEGMENTATION 52
CHART 24 SANOFI SA: GEOGRAPHIC REVENUE 53
CHART 25 SANOFI SA: SWOT ANALYSIS 54
CHART 26 BAYER AG: OVERVIEW SNAPSHOT 56
CHART 27 BAYER AG: BUSINESS UNITS 57
CHART 28 BAYER GA: GEOGRAPHICAL PRESENCE 58
CHART 29 BAYER AG: SWOT ANALYSIS 59
CHART 30 JOHNSON & JOHNSON: OVERVIEW SNAPSHOT 62
CHART 31 JOHNSON & JOHNSON: BUSINESS UNITS 63
CHART 32 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE 64
CHART 33 JOHNSON & JOHNSON: SWOT ANALYSIS 66
CHART 34 GLAXOSMITHKLINE PLC: OVERVIEW SNAPSHOT 68
CHART 35 GLAXOSMITHKLINE PLC: BUSINESS UNITS 69
CHART 36 GLAXOSMITHKLINE PLC: GEOGRAPHIC PRESENCE 71
CHART 37 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 72

REPORTS VIEWED RECENTLY

SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$2750
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$3500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$4500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Prednisone API Sales Market Report 2021
Global Prednisone API Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-12K5596
Mon Jun 21 00:00:00 UTC 2021

Add to Cart

Global Rabeprazole Sales Market Report 2021
Global Rabeprazole Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-37S5378
Mon Jun 21 00:00:00 UTC 2021

Add to Cart

Global Apomorphine Hydrochloride Injection Sales Market Report 2021
Global Apomorphine Hydrochloride Injection Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-29I5393
Mon Jun 21 00:00:00 UTC 2021

Add to Cart

Global Dexamethasone API Sales Market Report 2021
Global Dexamethasone API Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-3T5867
Mon Jun 21 00:00:00 UTC 2021

Add to Cart